← back to search

Yaqing Zhang

Zhengzhou University · CN

Area of research

Oncology · Molecular Biology

Research interest

Research interests include Pancreatic and Hepatic Oncology Research, Epigenetics and DNA Methylation, Immune cells in cancer, and Cancer Immunotherapy and Biomarkers.

h-index

37

citations

5,624

works

234

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer

Journal of Advanced Research 2023cited by 25position: middledoi

Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer

Clinical Cancer Research 2021cited by 272position: middledoi

Extensive 5’-Surveillance Guards Against Non-Canonical NAD-Caps of Nuclear mRNAs in Yeast

bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 8position: firstdoi

Identification, Biosynthesis, and Decapping of NAD-Capped RNAs in B. subtilis

Cell Reports 2018cited by 86position: middledoi

Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism

Carcinogenesis 2015cited by 33position: middledoi

Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis

Cancer Research 2013cited by 198position: firstdoi

Phosphorylation of BRAF by AMPK Impairs BRAF-KSR1 Association and Cell Proliferation

Molecular Cell 2013cited by 136position: middledoi

Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice

Journal of Clinical Investigation 2012cited by 769position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marina Pasca di Magliano · Michigan United3 papers (2012–2015)— · 2 papers (2018–2020)Meredith A. Collins · Rutgers, The State University of New Jersey2 papers (2012–2015)Diane M. Simeone · NYU Langone’s Laura and Isaac Perlmutter Cancer Center2 papers (2013–2015)Andres Jäschke · Heidelberg University2 papers (2018–2020)Wei Yan · The University of Texas Health Science Center at San Antonio2 papers (2013–2015)Filip Bednar · University of Michigan–Ann Arbor2 papers (2012–2015)Heather Schofield · Cornell University2 papers (2013–2015)Stefanie Galbán · Purdue University West Lafayette1 papers (2012–2012)Matthias Hebrok · University of California, San Francisco1 papers (2013–2013)Jianming Tang · The First Affiliated Hospital, Sun Yat-sen University1 papers (2023–2023)Walter E. Haefeli · Chirurgische Universitätsklinik Heidelberg1 papers (2018–2018)Jürgen Burhenne · Columbus Oncology and Hematology Associates1 papers (2018–2018)David Ibberson · Heidelberg University1 papers (2020–2020)Jaime Eberle-Singh · Center for Cancer Research1 papers (2015–2015)Volkan Adsay · Koç University1 papers (2012–2012)Hans Hombauer · German Cancer Research Center1 papers (2020–2020)Guansheng Zhong · Indiana University School of Medicine1 papers (2023–2023)— · 1 papers (2018–2018)Che‐Hung Shen · Columbia University1 papers (2013–2013)